ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 3c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.47), $0.03 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Cinema United: issues joint letter to state AGs and Paramount